Abstract No. 27: Do the RECIST Amendment for Tumor Response Evaluation criteria correlate better with patient outcomes than the RECIST 1.1 criteria after conventional transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC)?

✍ Scribed by Kranokpiraksa, P.; Kachura, J.R.; Beecroft, R.; Tan, K.; Rajan, D.K.; Jaskolka, J.D.

• Book ID: 123538340
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 135 KB
• Volume: 21
• Category: Article
• ISSN: 1051-0443
• DOI: 10.1016/j.jvir.2009.12.170